SOUTH SAN FRANCISCO, Calif., January 12, 2026--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ ...
Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude Children's Research Hospital scientists. Many diseases, including cancers, ...
In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...
Understanding and preventing drug side effects holds a profound influence on drug development and utilization, profoundly impacting patients’ physical and mental well-being. Traditional artificial ...
Drug diversion remains a persistent challenge for hospitals and health systems, putting both patient safety and workforce wellbeing at risk. The impact doesn’t stop there – diversion can also create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback